Regulation of gene expression in African Trypanosomes. (360G-Wellcome-077716_Z_05_Z)

£222,302

Trypanosoma brucei is the causative agent of sleeping sickness in man and Nagana in cattle. One interesting aspect of trypanosome biology is the almost complete absence of transcriptional control, which is the major control point for regulating gene expression in most eukaryotes. Therefore it would not be surprising to identify novel mechanisms of post-transcriptional gene regulation exemplified in these organisms that are important but subtle in other eukaryotes. Understanding this fundamental aspect of trypanosome biology may reveal an Achilles heel in these pathogenic parasites. My genome wide survey of the 2004 completed T.brucei genome sequence suggests that the novel CCCH zinc finger family of proteins, that has been implicated in post-transcriptional regulation of gene expression via RNA binding, may be of great importance in trypanosomes. This project will define the lifecycle specific expression pattern, cellular consequences of perturbed expression, cellular localisation and mechanism of RNA binding for 4 selected T.brucei CCCH proteins. One of these will be prioritise for further dissection via more detailed processing analysis and expression profiling. This will determine the regulatory extent and cellular function(s) of these novel CCCH proteins and indicate the significance of the CCCH family of proteins in T.brucei regulated gene expression.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 222302
Applicant Surname Hendriks
Approval Committee Immunology and Infectious Disease Funding Committee
Award Date 2005-10-25T00:00:00+00:00
Financial Year 2005/06
Grant Programme: Title Project Grant
Internal ID 077716/Z/05/Z
Lead Applicant Dr Edward Hendriks
Partnership Value 222302
Planned Dates: End Date 2009-03-05T00:00:00+00:00
Planned Dates: Start Date 2006-03-06T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London